The EBV glycoprotein gp340 was initially used as a prototype subunit vaccine that offered protection against EBV infection or EBV-induced lymphomas in cottontop tamarins, but the gp340-specific antibody was unable to neutralize EBV in vitro [112,113,114]. The gene discussed is DMBT1; the disease is Epstein-Barr virus infection.